This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Retinal/ Chorioretinal Disorders  • Alert me on articles by topic

Robert J. Casson, MB, BS(Hons), FRANZCO; Glyn Chidlow, DPhil; James P. M. Wood, DPhil; Neville N. Osborne, DSc

Arch Ophthalmol. 2004;122:361-366.

Objective  To determine the effect of hyperglycemia and intraocular glucose delivery on ischemic retinal injury.

Methods  Experimental diabetes was induced in age- and sex-matched Wistar rats by an injection of streptozocin. The functional and structural retinal injury in these rats after a period of pressure-induced retinal ischemia was compared with the injury in appropriate controls and with rats made hyperglycemic by an injection of systemic glucose. The effect of high intraocular pressure–induced ischemia with the use of several different isotonic substrates in the elevated reservoir (isotonic sodium chloride solution, glucose, 2-deoxyglucose, and lactate) was also determined. Electroretinography, reverse transcriptase polymerase chain reaction, and histologic examination were used to assess the retinal injury.

Results  Streptozocin-induced diabetes, glucose injection–induced preexisting hyperglycemia, and intraocular glucose delivery during ischemia markedly reduced the functional and structural ischemic retinal injury. Neither postischemic hyperglycemia nor the intraocular delivery of lactate significantly affected the ischemic injury; however, the intraocular delivery of 2-deoxyglucose significantly exacerbated the retinal injury.

Conclusion  Preexisting hyperglycemia and the intraocular delivery of glucose markedly attenuate ischemic retinal injury.

Clinical Relevance  These findings highlight fundamental differences in energy metabolism between brain and retina, have important implications for the pathophysiology of diabetic retinopathy, and may lead to novel therapeutic strategies for ischemic retinopathies.

From the Nuffield Laboratory of Ophthalmology, Oxford University, Oxford, England. The authors have no relevant financial interest in this article.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dendrite Remodeling and Other Abnormalities in the Retinal Ganglion Cells of Ins2Akita Diabetic Mice
Gastinger et al.
IOVS 2008;49:2635-2642.
ABSTRACT | FULL TEXT  

Paired-Flash Identification of Rod and Cone Dysfunction in the Diabetic Rat
Phipps et al.
IOVS 2004;45:4592-4600.
ABSTRACT | FULL TEXT